![]() 莫扎伐普坦盐酸盐结构式
![]() |
常用名 | 莫扎伐普坦盐酸盐 | 英文名 | OPC 31260 HCl |
---|---|---|---|---|
CAS号 | 138470-70-9 | 分子量 | 463.999 | |
密度 | N/A | 沸点 | 543ºC at 760mmHg | |
分子式 | C27H30ClN3O2 | 熔点 | N/A | |
MSDS | 中文版 美版 | 闪点 | 282.2ºC |
莫扎伐普坦盐酸盐用途Mozavaptan, also known as OPC 31260, is a vasopressin receptor antagonist marketed by Otsuka. In Japan, it was approved in October 2006 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH) due to ADH producing tumors. |
中文名 | 莫扎伐普坦盐酸盐 |
---|---|
英文名 | N-[4-[5-(dimethylamino)-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl]phenyl]-2-methylbenzamide,hydrochloride |
中文别名 | 5-(二甲基氨基)-1-[4-(2-甲基苯甲酰胺基)苯甲酰]-2,3,4,5-四氢-1H-苯并氮杂卓盐酸盐 | 盐酸莫扎伐普坦 |
英文别名 | 更多 |
沸点 | 543ºC at 760mmHg |
---|---|
分子式 | C27H30ClN3O2 |
分子量 | 463.999 |
闪点 | 282.2ºC |
精确质量 | 463.202667 |
PSA | 52.65000 |
LogP | 6.23060 |
蒸汽压 | 7.49E-12mmHg at 25°C |
储存条件 | -20°C,密封,干燥 |
Benzamide, N-[4-[[5-(dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl]phenyl]-2-methyl-, hydrochloride (1:1) |
N-(4-{[5-(Dimethylamino)-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]carbonyl}phenyl)-2-methylbenzamide hydrochloride (1:1) |
Mozavaptan Hydrochloride |
Physuline |
UNII:F39AR1YW1O |
UNII-F39AR1YW1O |
Mozavaptane hydrochloride (JAN) |
Mozavaptan HCl |